Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Tildrakizumab-asmn
Determining the interaction of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets and Tildrakizumab-asmn and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dasabuvir / ombitasvir / paritaprevir / ritonavir
Brand name: Viekira XR, Viekira Pak
Synonyms: Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets, and Dasabuvir
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Tildrakizumab-asmn Subcutaneous
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Tilia Fe
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Tiludronate
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Timentin
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Timentin Add-Vantage
- Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets-Timentin Injection
- Tildrakizumab-asmn-Omeclamox-Pak
- Tildrakizumab-asmn-Omega-3 Fatty Acid Capsules
- Tildrakizumab-asmn-Omega-3 Fatty Acids
- Tildrakizumab-asmn-Omega-3 polyunsaturated fatty acids
- Tildrakizumab-asmn-Omega-3-acid ethyl esters
- Tildrakizumab-asmn-Omega-3-carboxylic acids